Experimental Proof

Part of the Cancer Treatment and Research book series (CTAR, volume 154)


The results of an experiment should be used to validate or refute a hypothesis, not to generate one.


Stem Cell Cancer Stem Cell Circulate Tumor Cell Spermatogonial Stem Cell Unique Stem Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kolata G (2009) Forty years’ war. Advances elusive in the drive to cure cancer. New York Times. April 24, 2009: HealthGoogle Scholar
  2. 2.
    Mani SA, Guo W, Liao M-J et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715CrossRefPubMedGoogle Scholar
  3. 3.
    Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14:818–829CrossRefPubMedGoogle Scholar
  4. 4.
    Chang JC, Creighton C, Landis M et al (2008) Gene signature of cancer stem cells in an intrinsic subgroup of breast cancers with mesenchymal properties [abstr]. J Clin Oncol 26(May 20 suppl). Abstract 11009Google Scholar
  5. 5.
    Stevens LC (1964) Experimental production of testicular teratomas in mice. Proc Natl Acad Sci USA 52:654–661CrossRefPubMedGoogle Scholar
  6. 6.
    Damjanov I, Solter D (1974) Embryo-derived teratocarcinomas elicit splenomegaly in syngeneic host. Nature 249:569–571CrossRefPubMedGoogle Scholar
  7. 7.
    Mintz B, Illmensee K (1975) Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 72:3585–3589CrossRefPubMedGoogle Scholar
  8. 8.
    Roy NS, Cleren C, Singh SK et al (2006) Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12:1259–1268, Erratum in Nat Med 2007;13(3):385CrossRefPubMedGoogle Scholar
  9. 9.
    Kroon E, Martinson LA, Kadoya K et al (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443–452CrossRefPubMedGoogle Scholar
  10. 10.
    Folkerth RD, Durso R (1996) Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 46:1219–1225PubMedGoogle Scholar
  11. 11.
    Amariglio N, Hirshberg A, Scheithauer BW et al (2009) Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6:e1000029CrossRefPubMedGoogle Scholar
  12. 12.
    Houghton J, Stoicov C, Nomura S et al (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568–1571CrossRefPubMedGoogle Scholar
  13. 13.
    Aractingi S, Kanitakis J, Euvrard S et al (2005) Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res 65:1755–1760CrossRefPubMedGoogle Scholar
  14. 14.
    Barsky SH, Ye Y, Xiao Y et al (2008) Insights into the stem cell origin of human cancers by studying a registry of bone marrow and other organ transplant recipients who later developed solid tumors [abstr]. J Clin Oncol 26(May 20 suppl). Abstract 110010Google Scholar
  15. 15.
    Cheng W, Liu J, Yoshida H et al (2005) Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med 11:531–537CrossRefPubMedGoogle Scholar
  16. 16.
    Ince TA, Richardson AL, Bell GW et al (2007) Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 12:160–170CrossRefPubMedGoogle Scholar
  17. 17.
    Perou CM, Sørlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752CrossRefPubMedGoogle Scholar
  18. 18.
    van de Vijver MJ, He YD, van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009CrossRefPubMedGoogle Scholar
  19. 19.
    Ye Q-H, Qin L-X, Forgues M et al (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9:416–423CrossRefPubMedGoogle Scholar
  20. 20.
    Cohen SJ, Punt CJ, Iannotti N et al (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal carcinoma. J Clin Oncol 26:3213–3221, Erratum in J Clin Oncol 2009;27(11):1923CrossRefPubMedGoogle Scholar
  21. 21.
    Cristofanilli M, Budd GT, Ellis MJ et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781–791CrossRefPubMedGoogle Scholar
  22. 22.
    de Bono JS, Scher HI, Montgomery RB et al (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14:6302–6309, Erratum in Clin Cancer Res 2009;15(4):1506CrossRefPubMedGoogle Scholar
  23. 23.
    Danila DC, Heller G, Gignac GA et al (2007) Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 13:7053–7058CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.The University of Texas M. D. Anderson Cancer CenterHoustonUSA

Personalised recommendations